Louis F. Fabre, MD., Ph.D. — Dr. Fabre has served as Chairman of the Board and Secretary since May 1993; served as President from September 1992 to May, 1993 and has served as a director since September 1992. Since 1973, Dr. Fabre has been a licensed physician and has served as chief executive officer of Fabre Research Clinics, Inc. involved in clinical research relating to the development of psychiatric drugs. Dr. Fabre has been Chief Executive Officer of Clinical Evaluations, Inc. since 1988. Through Fabre Research Clinics, Inc., Dr. Fabre has been involved in the clinical development of more than 17 psychiatric drugs approved in the U.S. since 1973 and was involved in pivotal studies for the drugs Prozac, Zoloft, Xanax, Halcion, Desyrel, Wellbutrin, Paxil, ProSom, Asendin, Doral, Paxipam, Effexor, Zyprexa and Seroquel. Dr. Fabre has been involved in the private practice of psychiatry since May 1973. Dr. Fabre was awarded a Ph.D. in Physiology at Case Western Reserve in 1966, obtained his M.D. at Baylor College of Medicine in 1969, and completed his psychiatric residence at Baylor affiliated hospitals in Houston, Texas from 1969 to 1973. He has been board certified in psychiatry since 1976, and a certified laboratory director since 1978.
2007-03-14 12:14:33
·
answer #2
·
answered by Indiana Frenchman 7
·
1⤊
0⤋
I know him personally, and have for quite sometime. What information are you looking for?
2007-03-19 22:18:58
·
answer #3
·
answered by Anonymous
·
0⤊
0⤋